Solid Biosciences Inc.
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophi…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Solid Biosciences Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Solid Biosciences Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Solid Biosciences Inc..